Detailed Notes on M3541
Of note, in the placebo team an increased proportion of patients in location 1 were taking corticosteroids compared with location 2, While regional differences in use of those medicines were considerably less pronounced in sufferers treated with sifalimumab. The necessity of this observation to clarify the increased placebo responses noticed in loc